Cancer related adverse events associated with use of proton pump inhibitors and histamine-2 receptor antagonists: A real-world analysis using the FDA adverse event reporting system
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12342331/?tool=EBI |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849331530465280000 |
|---|---|
| author | Bowen Wang Zheyun Song Shan Lan Xiubi Chen Xida Yan Xue-Feng Jiao |
| author_facet | Bowen Wang Zheyun Song Shan Lan Xiubi Chen Xida Yan Xue-Feng Jiao |
| author_sort | Bowen Wang |
| collection | DOAJ |
| format | Article |
| id | doaj-art-2f1643dc94e443c7a024466b85f1ebe8 |
| institution | Kabale University |
| issn | 1932-6203 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj-art-2f1643dc94e443c7a024466b85f1ebe82025-08-20T03:46:33ZengPublic Library of Science (PLoS)PLoS ONE1932-62032025-01-01208Cancer related adverse events associated with use of proton pump inhibitors and histamine-2 receptor antagonists: A real-world analysis using the FDA adverse event reporting systemBowen WangZheyun SongShan LanXiubi ChenXida YanXue-Feng Jiaohttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC12342331/?tool=EBI |
| spellingShingle | Bowen Wang Zheyun Song Shan Lan Xiubi Chen Xida Yan Xue-Feng Jiao Cancer related adverse events associated with use of proton pump inhibitors and histamine-2 receptor antagonists: A real-world analysis using the FDA adverse event reporting system PLoS ONE |
| title | Cancer related adverse events associated with use of proton pump inhibitors and histamine-2 receptor antagonists: A real-world analysis using the FDA adverse event reporting system |
| title_full | Cancer related adverse events associated with use of proton pump inhibitors and histamine-2 receptor antagonists: A real-world analysis using the FDA adverse event reporting system |
| title_fullStr | Cancer related adverse events associated with use of proton pump inhibitors and histamine-2 receptor antagonists: A real-world analysis using the FDA adverse event reporting system |
| title_full_unstemmed | Cancer related adverse events associated with use of proton pump inhibitors and histamine-2 receptor antagonists: A real-world analysis using the FDA adverse event reporting system |
| title_short | Cancer related adverse events associated with use of proton pump inhibitors and histamine-2 receptor antagonists: A real-world analysis using the FDA adverse event reporting system |
| title_sort | cancer related adverse events associated with use of proton pump inhibitors and histamine 2 receptor antagonists a real world analysis using the fda adverse event reporting system |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12342331/?tool=EBI |
| work_keys_str_mv | AT bowenwang cancerrelatedadverseeventsassociatedwithuseofprotonpumpinhibitorsandhistamine2receptorantagonistsarealworldanalysisusingthefdaadverseeventreportingsystem AT zheyunsong cancerrelatedadverseeventsassociatedwithuseofprotonpumpinhibitorsandhistamine2receptorantagonistsarealworldanalysisusingthefdaadverseeventreportingsystem AT shanlan cancerrelatedadverseeventsassociatedwithuseofprotonpumpinhibitorsandhistamine2receptorantagonistsarealworldanalysisusingthefdaadverseeventreportingsystem AT xiubichen cancerrelatedadverseeventsassociatedwithuseofprotonpumpinhibitorsandhistamine2receptorantagonistsarealworldanalysisusingthefdaadverseeventreportingsystem AT xidayan cancerrelatedadverseeventsassociatedwithuseofprotonpumpinhibitorsandhistamine2receptorantagonistsarealworldanalysisusingthefdaadverseeventreportingsystem AT xuefengjiao cancerrelatedadverseeventsassociatedwithuseofprotonpumpinhibitorsandhistamine2receptorantagonistsarealworldanalysisusingthefdaadverseeventreportingsystem |